Market Cap

Axcella Health Inc. Market Capitalization:

$1.2 Million

USD as of Dec. 1, 2023

business Axcella Health Inc. Company Profile

Axcella Health Inc. Main Stock Listing

NASDAQ: AXLA

Market Capitalization History of Axcella Health Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Axcella Health Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $32.1 M -73.86%
Jan. 1, 2022 $122.7 M -68.57%
Jan. 1, 2021 $390.3 M 12.40%
Jan. 1, 2020 $347.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Axcella Health Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Axcella Health Inc. has the following listings and related stock indices.


Stock: NASDAQ: AXLA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.